← Back to headlines
Piper Sandler Lowers Akebia Therapeutics Price Target to $4 Following Year-End Reports
Piper Sandler has reduced its price target for Akebia Therapeutics (AKBA) to $4, updating its estimates after the company's year-end reports.
20 Feb, 00:28 — 20 Feb, 00:28
ℹOnly 1 source covers this story
Read at source (1 outlet)
Related Stories
Pakistan Launches Retaliatory Strikes on Afghanistan, Taliban Reports Dozens Killed
3m ago
Chef Arrested in Hong Kong for Allegedly Spraying Unknown Liquid on Women
3m ago
Hong Kong Official Warns Tai Po Fire Victims on Property Buy-Back Offer
3m ago
Jeonbuk State Implements Global Population Strategy to Attract Foreign Residents
23m ago